Reprogrammed macrophage-derived nanovesicle–lipid nanoparticle hybrids for cardiac siRUNX1 delivery: Therapeutic evaluation in Ang II-induced cardiac remodeling
Materials Today Bio
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Reprogrammed macrophage-derived nanovesicle–lipid nanoparticle hybrids for cardiac siRUNX1 delivery: Therapeutic evaluation in Ang II-induced cardiac remodeling. // Materials Today Bio. – URL: https://www.sciencedirect.com/science/article/pii/S2590006426010458?dgcid=rss_sd_all
Reprogrammed macrophage-derived nanovesicle–lipid nanoparticle hybrids for cardiac siRUNX1 delivery: Therapeutic evaluation in Ang II-induced cardiac remodeling. Materials Today Bio. https://www.sciencedirect.com/science/article/pii/S2590006426010458?dgcid=rss_sd_all
“Reprogrammed macrophage-derived nanovesicle–lipid nanoparticle hybrids for cardiac siRUNX1 delivery: Therapeutic evaluation in Ang II-induced cardiac remodeling.” Materials Today Bio.
@article{article5309,
title = {Reprogrammed macrophage-derived nanovesicle–lipid nanoparticle hybrids for cardiac siRUNX1 delivery: Therapeutic evaluation in Ang II-induced cardiac remodeling},
journal = {Materials Today Bio},
url = {https://www.sciencedirect.com/science/article/pii/S2590006426010458?dgcid=rss_sd_all}
}